Revolution Medicines

mentions 2 type Person feed RSS

// recent coverage 2 mentions

12:50

2026-09-01

ocregister.com

artificial-intelligence

‘I’m still here’: Patients see early promising results from new pancreatic cancer pill

The FDA approved daraxonrasib (Rasonque), a once-daily pill from Revolution Medicines for stage 4 pancreatic cancer, which nearly doubled median survival to 13.2 months from 6.7 months with chemothera…

12:01

2026-06-06

bigpharmasharma.com

ai-startups

Last Week Tonight in BioPharma: Week of June 1st, 2026

Revolution Medicines presented complete Phase 3 data for daraxonrasib at ASCO 2026, showing the drug cut the risk of death by 60% and nearly doubled median overall survival to 13.2 months versus 6.7 m…

// co-occurs with top 8 entities

Daraxonrasib 1 ASCO 1 Otsuka 1 IgAN 1 CAR-T 1 NewLimit 1 Big Pharma Sharma 1 FDA 1

// topics top 6 topics

ai startups 1 ai research 1 ai products 1 ai tools 1 ai infrastructure 1 artificial intelligence 1